Phase 0 Clinical Trials: Recommendations From the Task Force on Methodology for the Development of Innovative Cancer Therapies

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2008.10.024
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association's Task Force on the Development of Stroke Systems

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2005English

Curriculum Recommendations of the AACP-PSSC Task Force on Caring for the Underserved

American Journal of Pharmaceutical Education
PharmacologyPharmacyMedicineToxicologyEducationPharmaceutics
2008English

Recommendations of the wwPDB NMR Validation Task Force

Structure
Structural BiologyMolecular Biology
2013English

Recommendations for Data Monitoring Committees From the Clinical Trials Transformation Initiative

Clinical Trials
MedicinePharmacology
2017English

The Task Force Report: The Reasoning Behind the Recommendations

Journal of Economic Perspectives
EconomicsEconometrics
1988English

Phase I Cancer Clinical Trials

British Journal of Cancer
Cancer ResearchOncology
2007English

Clinical Pathology Testing Recommendations, DACC-ASVCP Regulatory Task Force Response

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
1993English

Innovative Methods for Biomarker Discovery in the Evaluation and Development of Cancer Precision Therapies

Cancer and Metastasis Reviews
Cancer ResearchOncology
2018English

Towards Universal Learning: Recommendations From the Learning Metrics Task Force. Summary Report

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy